Stem cells from umbilical cords are increasingly being stored in private banks for autologous use. “Newsweek” added to the debate writing about Dallas Hextell, who at the age of 8 months was diagnosed with cerebral paralysis, a condition normally caused by serious neural damage due to oxygen deprivation in the uterus or at birth. His parents consulted various neurologists, but the possibility of a recovery was virtually non-existant.
About 9 months later, when given the opportunity to participate in a Duke University clinical study on autologous stem cell transplants (stem cells that are stored for later use by
Image via Wikipedia
On February 15 the first bank to preserve and study stem cells obtained from the umbilical cord and umbilical cord membrane was opened. The bank, which received investments from Mekophar (pharmaceutical company) and the Minister of Science and Technology, will use technology developed by CellResearch Corporation in Singapore.
The bank will perform research to improve the quality of the preservation of stem cells and tests for practical applications to treat incurable diseases.
It’s the same umbilical cord that helped to bring Jakob Bielskis a baby brother three weeks ago.
Now, that cord and its treasure trove of genetic material may bring Jakob a clear view of his younger sibling in the future, as doctors use cord-blood stem cells to reverse the blindness the older boy was born with.
That’s the hope of Jakob’s mom and dad, Dawn Villeneuve and Richard Bielskis, as they go through the first frazzled weeks with a new baby — like any infant, Jaxon Bielskis is wide awake at 1:30 a.m., and asleep during the day.
“He’s doing great —
(…) In January, recognizing the worsening situation, the health ministry announced a package of rules for the industry. Organizations using stem cells must register their research and clinical activities, the source of the stem cells and ethical procedures. The ministry asked local health authorities to halt any unapproved clinical use of stem cells in their regions. And it called for a nationwide moratorium on new clinical trials for stem-cell therapies, adding that patients in existing clinical trials should not be charged.
So far, however, the ministry’s clampdown has proved ineffective. According to a Ministry of Health spokesman, not one clinic
Image via Wikipedia
The subject of producing artificial blood from stem cells has become a hot topic in Italy. “Italy is close to reaching the same objective announced by British researchers, on a similar timeframe,” therefore possibly in three years, “but using adult stem cells. Certainly, it is one thing to say that in three years we will begin the experimental phase, it’s another thing to speak about industrial production. It needs to be specified that the procedure to produce artificial blood is very expensive. Therefore this would be a complementary solution, which will not replace